Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells.

MLA

Koga, Chikato, et al. “Reprogramming Using MicroRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells.” Annals of Surgical Oncology, vol. 21 Suppl 4, Dec. 2014, pp. S591–600. EBSCOhost, https://doi.org/10.1245/s10434-014-3705-7.

APA

Koga, C., Kobayashi, S., Nagano, H., Tomimaru, Y., Hama, N., Wada, H., Kawamoto, K., Eguchi, H., Konno, M., Ishii, H., Umeshita, K., Doki, Y., & Mori, M. (2014). Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells. Annals of Surgical Oncology, 21 Suppl 4, S591–S600. https://doi.org/10.1245/s10434-014-3705-7

Chicago

Koga, Chikato, Shogo Kobayashi, Hiroaki Nagano, Yoshito Tomimaru, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, et al. 2014. “Reprogramming Using MicroRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells.” Annals of Surgical Oncology 21 Suppl 4 (December): S591–600. doi:10.1245/s10434-014-3705-7.